Swastika Maitra

706 total citations · 1 hit paper
34 papers, 349 citations indexed

About

Swastika Maitra is a scholar working on Molecular Biology, Computational Theory and Mathematics and Oncology. According to data from OpenAlex, Swastika Maitra has authored 34 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 6 papers in Computational Theory and Mathematics and 5 papers in Oncology. Recurrent topics in Swastika Maitra's work include Extracellular vesicles in disease (11 papers), RNA Interference and Gene Delivery (7 papers) and Computational Drug Discovery Methods (6 papers). Swastika Maitra is often cited by papers focused on Extracellular vesicles in disease (11 papers), RNA Interference and Gene Delivery (7 papers) and Computational Drug Discovery Methods (6 papers). Swastika Maitra collaborates with scholars based in India, Saudi Arabia and Bangladesh. Swastika Maitra's co-authors include Nobendu Mukerjee, Arabinda Ghosh, Αθανάσιος Αλεξίου, Nanasaheb D. Thorat, Vetriselvan Subramaniyan, Daniel Ejim Uti, Rohit Sharma, Popat Mohite, Vinoth Kumarasamy and Mohamed M. Abdel‐Daim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Swastika Maitra

31 papers receiving 342 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome isolation and characterization for advanced diagnostic and therapeutic applications

2025 28 citations Nobendu Mukerjee, Arghya Bhattacharya et al. Materials Today Bio profile →

Peers

Countries citing papers authored by Swastika Maitra

Since Specialization

Citations

This map shows the geographic impact of Swastika Maitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swastika Maitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swastika Maitra more than expected).

Fields of papers citing papers by Swastika Maitra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swastika Maitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swastika Maitra. The network helps show where Swastika Maitra may publish in the future.

Co-authorship network of co-authors of Swastika Maitra

This figure shows the co-authorship network connecting the top 25 collaborators of Swastika Maitra. A scholar is included among the top collaborators of Swastika Maitra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swastika Maitra. Swastika Maitra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exosome isolation and characterization for advanced diagnostic and therapeutic applications breakdown → 2025 ·Materials Today Bio ·Nobendu Mukerjee, Arghya Bhattacharya, Swastika Maitra, Mandeep Kaur, Subbulakshmi Ganesan, (unknown), (unknown), Muhammad Rizwan, Kavindra Kumar Kesari, Tanveer A. Tabish, Nanasaheb D. Thorat	28
2	Click chemistry-based modified exosomes: Towards enhancing precision in cancer theranostics 2025 ·Chemical Engineering Journal ·Nobendu Mukerjee, Swastika Maitra, Mandeep Kaur, (unknown), (unknown), (unknown), Nanasaheb D. Thorat, Parshant Kumar Sharma, Ajeet Kaushik	6
3	Enhancing solubility and dissolution of felodipine using self-nanoemulsifying drug systems through in vitro evaluation 2025 ·Scientific Reports ·A. B. Pawar, (unknown), Ramdas Pandhare, Popat Mohite, (unknown), Vetriselvan Subramaniyan, (unknown), Swastika Maitra, (unknown), Daniel Ejim Uti, Ajoy Kumer	0
4	Design, synthesis, molecular docking and molecular dynamics studies of some 3-methoxy flavone derivatives as an anti-breast cancer agent 2025 ·Discover Oncology ·(unknown), (unknown), (unknown), Ritesh Bhole, (unknown), (unknown), Swastika Maitra, Daniel Ejim Uti, Magdi E. A. Zaki, Esther Ugo Alum	2
5	Tetracarpidium conophorum nuts (African walnuts) up‐regulated adiponectin and PPAR‐γ expressions with reciprocal suppression of TNF‐α gene in obesity 2024 ·Journal of Cellular and Molecular Medicine ·(unknown), Item Justin Atangwho, (unknown), Daniel Ejim Uti, (unknown), (unknown), Swastika Maitra, Vetriselvan Subramaniyan, Ling Shing Wong, Nada H. Aljarba, (unknown)	6
6	Interplay of precision therapeutics and MD study: Calocybe indica's potentials against cervical cancer and its interaction with VEGF via octadecanoic acid 2024 ·Journal of Cellular and Molecular Medicine ·(unknown), Preeti Verma, (unknown), (unknown), Swastika Maitra, Arup Kumar Mitra, Mohd Shahnawaz Khan, Torki A. Zughaibi, Shams Tabrez, Ajoy Kumer	3
7	Proteolysis‐targeting chimeras in antiviral therapy: Leveraging influenza virus and exosome‐mediated delivery for targeted protein degradation and therapeutic advancements 2024 ·Drug Development Research ·Nobendu Mukerjee, Swastika Maitra, Rohit Sharma	3
8	Harnessing PROTACs to combat H5N1 influenza: A new frontier in viral destruction 2024 ·Journal of Medical Virology ·Nobendu Mukerjee, Swastika Maitra, Dattatreya Mukherjee, Arabinda Ghosh, Αθανάσιος Αλεξίου, (unknown)	3
9	Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy 2024 ·ACS Omega ·Popat Mohite, (unknown), Ramdas Pandhare, Swastika Maitra, Fayez M. Saleh, (unknown), Hamdan S. Al-malky, Vinoth Kumarasamy, Vetriselvan Subramaniyan, Mohamed M. Abdel‐Daim, Daniel Ejim Uti	27
10	Development and characterization of a self-nano emulsifying drug delivery system (SNEDDS) for Ornidazole to improve solubility and oral bioavailability of BCS class II drugs 2024 ·Scientific Reports ·Popat Mohite, (unknown), (unknown), (unknown), Swastika Maitra, Vetriselvan Subramaniyan, Vinoth Kumarasamy, Daniel Ejim Uti, (unknown), (unknown), Ajoy Kumer, (unknown), (unknown)	8
11	Targeted therapies for HPV‐associated cervical cancer: Harnessing the potential of exosome‐based chipsets in combating leukemia and HPV‐mediated cervical cancer 2024 ·Journal of Medical Virology ·Swastika Maitra, Nobendu Mukerjee, (unknown), Arabinda Ghosh, Αθανάσιος Αλεξίου, Nanasaheb D. Thorat	9
12	Exosome-mediated PROTAC delivery for treatment of RNA viral infections and zoonosis 2024 ·Drug Discovery Today ·Nobendu Mukerjee, Swastika Maitra, Arabinda Ghosh, Αθανάσιος Αλεξίου, Nanasaheb D. Thorat	12
13	Unlocking Exosome-Based Theragnostic Signatures: Deciphering Secrets of Ovarian Cancer Metastasis 2023 ·ACS Omega ·(unknown), Sagnik Nag, Nobendu Mukerjee, Swastika Maitra, M. Raman, Neeraj Kumar Fuloria, Shivkanya Fuloria, Manab Deb Adhikari, Krishnan Anand, Nanasaheb D. Thorat, Vetriselvan Subramaniyan, Sukhamoy Gorai	15
14	Mechanistic inhibition of gastric cancer-associated bacteria Helicobacter pylori by selected phytocompounds: A new cutting-edge computational approach 2023 ·Heliyon ·Shopnil Akash, İmren Bayıl, (unknown), Nobendu Mukerjee, (unknown), Kuldeep Dhama, (unknown), Swastika Maitra, Mohamed Mohany, Salim S. Al‐Rejaie, Nemat Ali, Prabhakar Semwal, Rohit Sharma	20
15	Revolutionizing Human papillomavirus (HPV)‐related cancer therapies: Unveiling the promise of Proteolysis Targeting Chimeras (PROTACs) and Proteolysis Targeting Antibodies (PROTABs) in cancer nano‐vaccines 2023 ·Journal of Medical Virology ·Nobendu Mukerjee, Swastika Maitra, Sukhamoy Gorai, Arabinda Ghosh, Αθανάσιος Αλεξίου, Nanasaheb D. Thorat	13
16	Target specific inhibition of West Nile virus envelope glycoprotein and methyltransferase using phytocompounds: an in silico strategy leveraging molecular docking and dynamics simulation 2023 ·Frontiers in Microbiology ·Shopnil Akash, İmren Bayıl, (unknown), Nobendu Mukerjee, Swastika Maitra, Md. Rezaul Islam, Sanchaita Rajkhowa, Arabinda Ghosh, Sami A. Al‐Hussain, Magdi E. A. Zaki, Vikash Jaiswal, Sanjit Sah, Joshuan J. Barboza, Ranjit Sah	16
17	From nature to nanotechnology: The interplay of traditional medicine, green chemistry, and biogenic metallic phytonanoparticles in modern healthcare innovation and sustainability 2023 ·Biomedicine & Pharmacotherapy ·Abhijeet Puri, Popat Mohite, Swastika Maitra, Vetriselvan Subramaniyan, Vinoth Kumarasamy, Daniel Ejim Uti, Amany A. Sayed, Fatma M. El‐Demerdash, Mohammad Algahtani, Attalla F. El‐kott, (unknown), (unknown), Mohamed M. Abdel‐Daim, Item Justin Atangwho	52
18	Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery Approaches 2022 ·Cells ·Haruna Isiyaku Umar, (unknown), Nobendu Mukerjee, Abdullahi Tunde Aborode, Mohammad Mehedi Hasan, Swastika Maitra, (unknown), (unknown), (unknown), (unknown), Mohammed M. Alshehri, (unknown), Nada H. Aljarba, Saad Alkahtani, Sumira Malik, Αθανάσιος Αλεξίου, Arabinda Ghosh, Md. Habibur Rahman	22
19	Omicron with threatened antagonistic consequences and are convoyed by new fangled risks – Correspondence 2022 ·International Journal of Surgery ·Nobendu Mukerjee, Swastika Maitra, (unknown), Sumira Malik, Αθανάσιος Αλεξίου, Arabinda Ghosh	0
20	Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer’s Disease 2022 ·Oxidative Medicine and Cellular Longevity ·Biswajit Chakraborty, Nobendu Mukerjee, Swastika Maitra, Mehrukh Zehravi, Dattatreya Mukherjee, Arabinda Ghosh, Ehab El Sayed Massoud, Md. Habibur Rahman	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact